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Background: Colorectal cancer (CRC) is the second most common malignancy in the Saudi population. This study
aimed to review CRC data from the Saudi Cancer Registry (SCR) in order to evaluate the prognostic factors for CRC
survival in Saudi patients.
Methods: This study was a retrospective censored overall survival (OS) analysis of CRC data for the period
1994–2004 obtained from the SCR. Data were collected from all 13 administrative regions of the Kingdom of Saudi
Arabia (KSA) by the SCR in collaboration with the National Information Center of the Ministry of Interior. The
Kaplan-Meier method was used to calculate the cumulative survival rate, which was then stratified by gender and
by period (1994–1999 versus 2000–2004). The clinico-pathological variables that might affect CRC survival were
analyzed by Cox regression analysis.
Results: Between 1994 and 2004, 549 CRC cases were diagnosed (363 [66.1%] in males and 186 [33.9%] in females).
The OS for CRC during this period was 44.6% (44.7% for 1994–1999 and 44.3% for 2000–2004 [p=0.7]). There was a
significant (p=0.003) discrepancy of 9.6% between the male five-year OS (41.0%) and the female five-year OS
(50.6%). The five-year OS was 63.3% for patients with localized disease, 50.2% for those with regional disease, and
14.7% for patients with metastases. By Cox regression analysis, age and extent were significant prognostic factors of
survival in patients with colon cancer; the risk was higher in patients with distant metastasis (hazard ratio [HR], 2.53;
95% confidence interval [CI], 1.17-5.45; p=0.01). In patients with rectal cancer, the risk was lower in males (HR, 0.66;
CI, 0.45-0.98; p=0.04), but higher in patients with unknown tumor extent (HR, 3.70; 95% CI, 1.66-8.24; p=0.01).
Conclusions: The five-year OS for 1994–2004 was 44.6% for patients with CRC. More so, five-year OS based on
CRC stage was generally lower than the typically reported survival rates. The establishment of a national screening
program and increased access to specialized medical faculties may be necessary to improve CRC survival in
the KSA.
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Cancer is a major public health problem in the Kingdom
of Saudi Arabia (KSA) and many other countries. World-
wide, colorectal cancer (CRC) is the third most common
cancer in men and the second in women. The highest in-
cidence is in Australia, New Zealand and Western Europe,
while the lowest is in Africa and South-Central Asia [1].* Correspondence: mahwal@kau.edu.sa
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reproduction in any medium, provided the orBoth the incidence and mortality rates are lower in
women than in men. The highest mortality in both gen-
ders is in Central and Eastern Europe, and the lowest is in
Middle Africa [2].
The KSA is a low-risk country for CRC, but the inci-
dence seems to be increasing [3]. Although CRC is less
common in the KSA than in its counterpart Gulf Cooper-
ation Council States and in the West, this disease was the
second most common malignancy after breast cancer,
ranking first among men and third among women be-
tween 1994 and 2004 [4]. In 2004, six hundred forty-sevenal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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dian age at diagnosis was 60 years in men (range, 19–105
years) and 58 years in women (range 16–100 years) [4].
The age-standardized incidence rate in 2004 was 7.3 per
100,000 men and women based on cases diagnosed from
13 Saudi Cancer Registry (SCR) geographic sites. In the
same year, the World Health Organization (WHO)
reported that the age-standardized death rate (per 100,000
inhabitants) from CRC in the KSA was 8.3% [5].
In developing countries, the five-year survival rates
range from 28% to 42% [6,7], compared with more than
60% in the US, Japan and Switzerland [8,9]. In the KSA,
there are limited data on five-year survival rates for
patients with CRC. Thus, the aim of this study was to re-
view CRC data for the period 1994–2004 based on
reports from the SCR in order to evaluate the prognostic
factors for CRC survival in Saudi patients.Table 1 Baseline characteristics of the patientsa
Colon (n, %)
Number of patients 257 (46.8)





Grade I (Well diff) 26 (44.8)
Grade II (Mod diff) 157 (44.7)
Grade III (Poor diff) 25 (46.3)




Regional: Direct Ext 59 (54.6)
Regional: Lymph Node 12 (27.3)
Regional: Dir Ext and lymph node 64 (59.8)
Regional NOS 0 (0)








Not applicable 105 (51.5)
Abbreviations: Diff, differentiation; Dir, direct; Ext, extent; Mod, moderate; NOS, not
aData are presented as frequency (percent) unless otherwise specified.
bp<0.05 for χ2 test. Except for extent, the characteristics of the patients did not diffeMethods
This study was a retrospective censored overall survival
(OS) analysis of CRC data for the period 1994–2004
obtained from the SCR. The SCR is a population-based
registry that was established in 1992 under the jurisdic-
tion of the Ministry of Health [5]. It endeavors to com-
pile all cancer data from the Ministry of Health, private
and governmental hospitals, clinics, and laboratories
from all regions in the Kingdom.
Routine data were collected from all 13 administrative
regions of the KSA by the SCR. The SCR collaborated with
the National Information Center (NIC) of the Ministry of
Interior through Al-Elm Information Security Company in
order to calculate the five-year survival rates for Saudi
patients with CRC. Because Al-Elm has access to huge gov-
ernment databases, they can verify the vital status of cancer
patients through their Saudi national identity number.Cancer site
Recto-sigmoid (n, %) Rectum (n, %)
66 (12.0) 226 (41.2)
53.6 ± 17.3 54.3 ± 15.2
25 (13.4) 65 (34.9)
41 (11.3) 161 (44.4)
5 (8.6) 27 (46.6)
48 (13.7) 146 (41.6)
3 (5.6) 26 (48.1)
0 (0) 2 (33.3)
10 (12.5) 25 (31.3)
14 (11.5) 60 (49.2)
11 (10.2) 38 (35.2)
9 (20.5) 23 (52.3)
9 (8.4) 34 (31.8)
0 (0) 1 (100.0)
21 (14.8) 58 (40.8)
2 (8.0) 12 (48.0)
43 (12.5) 150 (43.5)
23 (11.3) 76 (37.3)
3 (12.5) 6 (25.0)
40 (12.5) 144 (44.9)
23 (11.3) 76 (37.3)
otherwise specified; Undiff, undifferentiated.
r significantly among different cancer patients.
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the availability of their Saudi national identity number)
was submitted to Al-Elm. Al-Elm analyzed only the data
of patients whose ten-digit national identity number
matched their complete four names in Arabic. Based on
the above, the company provided the SCR with informa-
tion on patient vital status and date of death (according
to the Hijri calendar) if dead. The date of death was then
converted to the equivalent Gregorian calendar date,
and survival period was calculated from the date of diag-
nosis to the date of death or last follow up.
The Kaplan-Meier method was used to calculate the cu-
mulative survival rate, and statistical significance was cal-
culated with the log-rank test. The cumulative survival
was then stratified by gender and by period (1994–1999
versus 2000–2004). Continuous variables were expressed
as mean ± SD and categorical variables as frequency (per-
cent). The clinico-pathological variables that might affect
CRC survival were analyzed by Cox regression analysis. A
p-value <0.05 was considered statistically significant.
The study was approved by the Biomedical Ethics Re-
search Committee of King Abdulaziz University (reference
number 816–12). To ensure confidentiality, the research-
ers signed a data use agreement.
Results
Five thousand one hundred forty-one cases of cancer, in-
cluding 549 of CRC were diagnosed between 1994 and
2004. Of the 549 cases of CRC, 363 were diagnosed in
males (66.9%) and 186 in females (44.6%). As shown in
Table 1, the mean age of the patients was 53.4 ± 14.7
years for patients with colon cancer, 53.6 ± 17.3 yearsFigure 1 Kaplan-Meier Curves for Colon, Recto-sigmoid, and Rectal Ca
patients with colon, recto-sigmoid, and rectal cancers was 40.9, 34.8%, andfor those with recto-sigmoid cancer, and 54.3 ± 15.2
years for those with rectal cancer. One hundred forty-
two patients (25.9%) had advanced disease at diagnosis,
and more than half of the patients (n=345; 62.8%) in the
study population died during the study period.
The five-year OS for 1994–2004 was 44.6%. The five-
year OS between 1994–1999 and 2000–2004 were simi-
lar (44.7% and 44.3%, respectively; p=0.7). There was a
significant (p=0.003) discrepancy of 9.6% between the
male five-year OS (41.0%) and the female five-year OS
(50.6%) for the period 1994–2004.
Based on cancer stage, the five-year OS rates for the
Saudi population were 63.3% for patients who had loca-
lized disease, 50.2% for those who had regional disease,
and 14.7% for patients with metastases. Overall survival
rate was highest for colon cancer followed by recto-
sigmoid and rectal cancers, respectively (Figure 1).
Results of Cox regression analysis are shown in Table 2.
Age and distant metastasis were significant prognostic
factors of survival in patients with colon cancer. The
risk of death was higher in patients with distant metasta-
sis (HR, 2.53; 95% CI, 1.17-5.45; p=0.01). The risk
was also higher in patients >65 years (hazard ratio [HR],
0.65; 95% confidence interval [CI], 0.43-0.97; p=0.03)
than in those aged 45–65 years (HR, 0.52; 95% CI,
0.33-0.81; p=0.01). Gender and grade were not signifi-
cant risk factors.
In patients with rectal cancer, the risk was lower in
males (HR, 0.66; CI, 0.45-0.98; p=0.04), but higher in
patients with unknown tumor extent (HR, 3.70; 95% CI,
1.66-8.24; p=0.01). Age and tumor grade were not sig-
nificant prognostic factors in these patients (Table 2).ncers. Legend: The cumulative (Cum) survival for 1994–2004 for
33.6%, respectively.
Table 2 Results of specific Cox regression modelsa
Variables HR 95% CI P-value
Colon
Age
<45 years (Ref) - - -
45-65 years 0.52 0.33 - 0.81 0.01
>65 years 0.65 0.43 - 0.97 0.03
Gender
Female (Ref) - - -
Male 0.74 0.52 - 1.05 0.10
Grade
Grade I (Well diff) (Ref) - - -
Grade II (Mod diff) 0.72 0.39 - 1.34 0.30
Grade III (Poor diff) 0.66 0.43 - 1.01 0.06
Grade IV (Undiff Anaplastic) 1.12 0.63 - 2.01 0.68
Unknown 0.55 0.13 - 2.37 0.42
Extension
Localized (Ref) - - -
Regional: Direct Ext 0.45 0.18 - 1.11 0.08
Regional: Lymph Node 0.65 0.28 - 1.51 0.32
Regional: Dir Ext and Lymph Node 0.81 0.25 - 2.58 0.72
Regional NOS 1.44 0.66 - 3.15 0.35
Distant Metastasis 2.53 1.17 - 5.45 0.01
Recto-sigmoid
Age
<45 years (Ref) - - -
45-65 years 0.53 0.19 - 1.46 0.22
>65 years 0.61 0.26 - 1.41 0.25
Gender
Female (Ref) - - -
Male 1.07 0.45 - 2.55 0.86
Grade
Grade I (Well diff) (Ref) - - -
Grade II (Mod diff) 0.85 0.19 - 3.73 0.83
Grade III (Poor diff) 0.55 0.21 - 1.48 0.24
Grade IV (Undiff Anaplastic) 0.88 0.20 - 3.84 0.86
Extent
Localized (Ref) - - -
Regional: Direct Ext 0.74 0.07 - 7.41 0.79
Regional: Lymph Node 1.83 0.17 - 18.95 0.61
Regional: Dir Ext and Lymph Node 2.12 0.21 - 20.94 0.52
Regional NOS 2.13 0.21 - 21.84 0.52
Distant Metastasis 5.74 0.67 - 49.01 0.11
Rectum
Age
<45 years (Ref) - - -
Table 2 Results of specific Cox regression modelsa
(Continued)
45-65 years 0.66 0.41 - 1.05 0.08
>65 years 0.72 0.48 - 1.08 0.11
Gender
Female (Ref) - - -
Male 0.66 0.45 - 0.98 0.04
Grade
Grade I (Well diff) (Ref) - - -
Grade II (Mod diff) 0.63 0.32 - 1.21 0.16
Grade III (Poor diff) 0.78 0.48 - 1.29 0.34
Grade IV (Undiff Anaplastic) 1.52 0.80 - 2.87 0.19
Unknown 0.75 0.09 - 6.04 0.79
Extension
Localized (Ref) - - -
Regional: Direct Ext 1.11 0.49 - 2.51 0.79
Regional: Lymph Node 1.01 0.42 - 2.45 0.97
Regional: Dir Ext and Lymph Node 0.86 0.33 - 2.24 0.75
Regional NOS 1.48 0.63 - 3.47 0.36
Distant Metastasis 3.92 0.46 - 33.25 0.21
Unknown 3.70 1.66 - 8.24 0.01
Abbreviations: CI, confidence interval; Diff, differentiation; Dir, direct; Ext,
extent; HR, hazard ratio; Mod, moderate; NOS, not otherwise specified; Ref,
reference, Undiff, undifferentiated.
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cant factors of survival in patients with recto-sigmoid
cancer (Table 2).
Discussion
The incidence of CRC among the Saudi population has
increased continuously over the last decade as in many
developing countries where the overall risk was previously
low [6]. In contrast, the incidence of CRC is declining in
the United States and in many developed countries world-
wide [10,11]. The geographic differences in CRC inci-
dence, as seen in studies of migrants moving from low- to
high-risk areas [7,8], are probably explained by environ-
mental factors and changing dietary patterns. Major risk
factors that have been identified include physical inactiv-
ity, high body mass index, and central adiposity [7,12,13].
Other risk factors include a diet poor in fiber and rich in
meat and fats [7,9], cigarette smoking, and genetic predis-
position [14,15]. Similarly, family history and a higher con-
sumption of meat and fats from animal sources were
associated with a greater risk of developing CRC in studies
conducted in the KSA [16-18].
CRC survival largely depends upon the stage of the
disease at diagnosis. Five-year survival rates for CRC
typically range from 90% for localized cancers, 70% for
regional cancers, to 10% for distant metastatic cancers
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all stages has increased considerably [19]. The relative
improvement in the five-year survival rates during this
period is reportedly better in countries with high life-
expectancy and improved access to specialized health
care services. In this study, OS rates based on CRC stage
are generally lower than the typically reported survival
rates. The five-year OS for 1994–2004 was 63.3% for
patients with localized disease, 50.2% for those with re-
gional disease, and 14.7% for patients with metastatic
disease. Lack of cancer-preventing and screening pro-
grams, accessibility to specialized centers, and efficient
diagnostic techniques to improve diagnosis, prognosis,
and hence survival [21] probably explain the lower sur-
vival rates in the KSA. These could also explain the lack
of improvement in the five-year OS between the periods
1994–1999 and 2000–2004.
There was a significant discrepancy of 9.6% between
the male five-year OS (41.0%) and the female five-year
OS (50.6%). In addition, gender was a significant prog-
nostic factor of survival in patients with rectal cancer;
however, there is no clear explanation for these findings.
According to the observations of some authors, the life-
time risk of dying from CRC is similar in both genders
because the life expectancy is on average higher in
women than men [21]. More recently, patient gender
has been extensively evaluated and most studies showed
that it was of no significance in predicting survival inde-
pendently of other factors [22-24].
As with most cancers, relative survival for CRC is
higher in patients younger than 70 years, even after the
higher background mortality in older persons is taken
into consideration [25]. In this study, age and tumor ex-
tent were significant prognostic factors for survival in
patients with colon cancer. Several studies have demon-
strated that old age and advanced disease stage were
prognostic factors associated with poor prognosis in
patients with CRC [26-29]. However, old age was
reported to be an independent prognostic factor, and be-
cause it may be associated with cardiovascular diseases
or other illnesses [30], overall survival tends to be poor
and not cancer-specific in older patients with CRC.
In several studies conducted abroad, other clinico-
pathological prognostic factors have been proposed, in-
cluding tumor location [31,32] and differentiation [23,31].
Unfortunately, there are no data that evaluate the prog-
nostic factors for CRC survival in Saudi patients. In this
study, patients with colon cancer had a better survival
than those with rectal cancer similar to the findings of
other authors [33]. Nevertheless, it seems that among all
the pathological factors that have been explored, those that
are related to early diagnosis of CRC cases are the most
important [33]. Thus, screening and early detection of
CRC should be a priority in Saudi health care programs.This study has some limitations. Given that the SCR
was only recently established, mortality data were not
available for patients with CRC in the KSA. Furthermore,
five-year relative OS could not be established as all deaths
were registered based on information from Al-Elm, which
could only verify the vital status of cancer patients
through their Saudi national identity number.
Conclusions
The five-year OS for 1994–2004 was 44.6% for patients
with CRC. More so, five-year OS based on CRC stage is
generally lower than the typically reported survival rates.
This raises concerns about CRC diagnosis and care in the
KSA. The establishment of a national screening program
and increased access to specialized medical faculties may
be necessary to improve CRC survival in the KSA. Further
exploration may be necessary to explain the 9.6% differ-
ence in five-year OS between males and females.
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